250 related articles for article (PubMed ID: 23922390)
1. Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.
McCord LA; Liang WG; Dowdell E; Kalas V; Hoey RJ; Koide A; Koide S; Tang WJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13827-32. PubMed ID: 23922390
[TBL] [Abstract][Full Text] [Related]
2. Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
Zhang Z; Liang WG; Bailey LJ; Tan YZ; Wei H; Wang A; Farcasanu M; Woods VA; McCord LA; Lee D; Shang W; Deprez-Poulain R; Deprez B; Liu DR; Koide A; Koide S; Kossiakoff AA; Li S; Carragher B; Potter CS; Tang WJ
Elife; 2018 Mar; 7():. PubMed ID: 29596046
[TBL] [Abstract][Full Text] [Related]
3. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
4. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.
Malito E; Ralat LA; Manolopoulou M; Tsay JL; Wadlington NL; Tang WJ
Biochemistry; 2008 Dec; 47(48):12822-34. PubMed ID: 18986166
[TBL] [Abstract][Full Text] [Related]
5. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
7. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
Shen Y; Joachimiak A; Rosner MR; Tang WJ
Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
[TBL] [Abstract][Full Text] [Related]
8. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE.
Im H; Manolopoulou M; Malito E; Shen Y; Zhao J; Neant-Fery M; Sun CY; Meredith SC; Sisodia SS; Leissring MA; Tang WJ
J Biol Chem; 2007 Aug; 282(35):25453-63. PubMed ID: 17613531
[TBL] [Abstract][Full Text] [Related]
9. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Structural Rearrangements of the Human Insulin-Degrading Enzyme through Molecular Dynamics Simulations.
Ghoula M; Janel N; Camproux AC; Moroy G
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163673
[TBL] [Abstract][Full Text] [Related]
11. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
12. Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.
de Tullio MB; Castelletto V; Hamley IW; Martino Adami PV; Morelli L; Castaño EM
PLoS One; 2013; 8(4):e59113. PubMed ID: 23593132
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition.
Li P; Kuo WL; Yousef M; Rosner MR; Tang WJ
Biochem Biophys Res Commun; 2006 May; 343(4):1032-7. PubMed ID: 16574064
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme.
Manolopoulou M; Guo Q; Malito E; Schilling AB; Tang WJ
J Biol Chem; 2009 May; 284(21):14177-88. PubMed ID: 19321446
[TBL] [Abstract][Full Text] [Related]
15. Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity.
Ramaraju B; Nelson SL; Zheng W; Ghirlando R; Deshmukh L
Biochemistry; 2021 Aug; 60(33):2519-2523. PubMed ID: 34342986
[TBL] [Abstract][Full Text] [Related]
16. Anion activation site of insulin-degrading enzyme.
Noinaj N; Song ES; Bhasin S; Alper BJ; Schmidt WK; Hersh LB; Rodgers DW
J Biol Chem; 2012 Jan; 287(1):48-57. PubMed ID: 22049080
[TBL] [Abstract][Full Text] [Related]
17. Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme.
Stefanidis L; Fusco ND; Cooper SE; Smith-Carpenter JE; Alper BJ
Biochemistry; 2018 Aug; 57(32):4903-4914. PubMed ID: 30004674
[TBL] [Abstract][Full Text] [Related]
18. Catalytic Mechanism of Amyloid-β Peptide Degradation by Insulin Degrading Enzyme: Insights from Quantum Mechanics and Molecular Mechanics Style Møller-Plesset Second Order Perturbation Theory Calculation.
Lai R; Tang WJ; Li H
J Chem Inf Model; 2018 Sep; 58(9):1926-1934. PubMed ID: 30133282
[TBL] [Abstract][Full Text] [Related]
19. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
Llovera RE; de Tullio M; Alonso LG; Leissring MA; Kaufman SB; Roher AE; de Prat Gay G; Morelli L; Castaño EM
J Biol Chem; 2008 Jun; 283(25):17039-48. PubMed ID: 18411275
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study.
Bora RP; Prabhakar R
Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
